Page 31 - ITPS-7-1
P. 31

INNOSC Theranostics and
            Pharmacological Sciences                                         Antiplatelet treatments in neurological patients






































            Figure  1.  Acute  ischemic  stroke  guidelines.  Simplified,  schematic  representation  of  the  2021  revised  American  Heart  Association/American  Stroke
            Association recommendations for antiplatelet therapy in patients with acute ischemic stroke, a prevalent neurovascular disorder. NIHSS indicates National
            Institutes of Health Stroke Scale, an assessment of the severity of ischemic activity.

                                                                 In addition, adhesion of differentiated smooth muscle
                                                               cells results in the formation of a histologically visible
                                                               initial neointima layer ~7  days after FDD implantation.
                                                               At the ~8-week mark, CD31  endothelial cells appear over
                                                                                     +
                                                               the neointimal layer of the smooth muscle antigen-positive
                                                               cells .
                                                                  [27]
                                                                 Most current studies regarding intracranial aneurysm
                                                               treatment utilized FDDs, pipeline embolization device,
                                                               and silk embolization device [31,32] . In treatment of cerebral
                                                               aneurysms, flow diversion has been shown to have a high
                                                               success rate of 93 – 95% and a low complication rate of
                                                               2.3 – 5.6% . Finally, a recent study has shown 83.5% and
                                                                       [33]
                                                               85.2% occlusion rates for 1-year and 3-year follow-ups,
                                                               and confirmed that FDDs are effective and safe in short-
                                                               term and long-term follow-ups .
                                                                                        [34]
            Figure 2. Flow diversion device following implantation.
                                                               3. Flow diversion devices compared to
            of FDDs . In addition, it has been shown that utilization   traditional embolization techniques
                   [29]
            of FDD in the treatment of aneurysms upregulates
            expression of apelin, cyclin B1, intercellular adhesion   Traditional methods for treating intracranial aneurysms
            molecule 2, and CXCL8, key genes involved in endothelial   include coil embolization (CE), stenting, and Woven
            function, mitogenic activity, cell cycle progression, and   EndoBridge (WEB) embolization (Figure 3).
            angiogenesis . Thus, it is believed that due to enhanced   CE involves the insertion of a microcatheter into the
                      [30]
            gene expression, FDD intrinsically facilitates upregulated   femoral artery before it moves to the site of the aneurysm
            endothelization .                                  for navigation. On reaching the aneurysm  site, small
                        [26]


            Volume 7 Issue 1 (2024)                         3                         https://doi.org/10.36922/itps.1202
   26   27   28   29   30   31   32   33   34   35   36